# SOLTI Cancer Research Group

Source: https://onco.cc/companies/solti/  
OnCo record `solti` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A Barcelona-based academic breast cancer group known for biomarker-driven trials that use PAM50 intrinsic subtypes to pick therapy.

## Summary

Founded in 1995, SOLTI is a Spanish academic research group that designs translational breast cancer trials around molecular subtyping. PAMELA showed the HER2-enriched intrinsic subtype predicts response to dual HER2 blockade without chemotherapy, PATRICIA tested palbociclib with trastuzumab, and HARMONIA compares ribociclib with palbociclib in HER2-enriched luminal disease. SOLTI works closely with Vall d'Hebron and Hospital Clínic investigators, partners with the Breast International Group and industry, and runs window-of-opportunity and neoadjuvant designs with serial biopsies. Patient advocates sit on its scientific committee.

## Fields

- Kind: Company
- Last checked: 2026-09-09
- Also known as: SOLTI
- Tags: cooperative-group
- HQ: Barcelona
- Type: cooperative-group
- Website: https://www.gruposolti.org

## Notes

- PAM50-guided trials (PAMELA, HARMONIA)
- CDK4/6 inhibitor trials (PATRICIA)
- Window-of-opportunity and neoadjuvant designs
- BIG member group

## Sources

- SOLTI: https://www.gruposolti.org

## Connected records

- drugs: [Palbociclib](https://onco.cc/drugs/palbociclib/), [Ribociclib](https://onco.cc/drugs/ribociclib/), [Trastuzumab](https://onco.cc/drugs/trastuzumab/)
- cancers: [HER2-positive breast cancer](https://onco.cc/cancers/breast-her2-positive/), [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/), [Triple-negative breast cancer (TNBC)](https://onco.cc/cancers/tnbc/)
- fronts: [Targeted Therapy](https://onco.cc/fronts/targeted-therapy/)
- technologies: [CDK4/6 inhibitors](https://onco.cc/technologies/cdk46-inhibitor/), [RNA sequencing & expression profiling](https://onco.cc/technologies/rna-seq/)
- companies: [Breast International Group (BIG)](https://onco.cc/companies/big/), [GEICAM Spanish Breast Cancer Group](https://onco.cc/companies/geicam/)
- institutions: [Vall d'Hebron University Hospital / VHIO](https://onco.cc/institutions/vall-dhebron/)
- terms: [PAM50 / intrinsic subtypes](https://onco.cc/terms/pam50/)
- people: [Aleix Prat](https://onco.cc/people/aleix-prat/), [Cristina Saura](https://onco.cc/people/cristina-saura/), [Eva Ciruelos](https://onco.cc/people/eva-ciruelos/), [Mafalda Oliveira](https://onco.cc/people/mafalda-oliveira/)

---
JSON: https://onco.cc/api/v1/entities/solti.json